Tg Therapeutics, Inc.

Ownership Transactions Reported by 7 Insiders

Symbol
TGTX on Nasdaq
Industry
Pharmaceutical Preparations
Location
2 Gansevoort Street, 9 Th Floor, New York, NY

Insiders trading volume in the past year

Tg Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Michael S. Weiss Ceo $249M Jan 5, 2024
Sean A. Power Cfo $13M -$809K -5.87% Feb 14, 2024
Kenneth Hoberman Director $4.22M Jun 19, 2024
Yann Echelard Director $3.89M Jun 19, 2024
Daniel Hume Director $3.83M Jun 19, 2024
Laurence N. Charney Director $3.78M -$684K -15.3% Jun 19, 2024
Sagar Lonial Director $1.77M -$513K -22.4% Jun 17, 2024

Recent Insider Transactions by Companies or Individuals for Tg Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.